US bans imports from 3 Chinese biotech companies over forced labor allegations
Supreme Court News
The Trump administration announced Wednesday that it will block imports from Chinese biotechnology firm BGI Group and two of its affiliates, citing alleged links to forced labor in Xinjiang, China's far-western ethnic region.
Beginning Thursday, U.S. Customs and Border Protection will stop goods from BGI Group, a major player in genetic sequencing, along with BGI Genomics and MGI Tech. According to the Department of Homeland Security, the companies either source materials from Xinjiang or work with the regional government in the recruitment and movement of forced labor drawn from persecuted ethnic groups there, including Uyghurs. DHS said BGI Group holds controlling stakes in both affiliates.
DHS cites genetic testing in Xinjiang
In its announcement, DHS said credible information, including corporate and government reports, shows the three companies have supported genetic testing in Xinjiang. The department said the collection and analysis of genetic material helps Chinese authorities monitor, surveil and repress ethnic minorities, including through forced labor.
The action falls under the Uyghur Forced Labor Prevention Act, which President Joe Biden signed into law at the end of 2021 in response to allegations of human rights abuses against Uyghurs and other Muslim minorities in Xinjiang. In August, the Trump administration added 43 Chinese companies to the law's blacklist, bringing the total to 187 entities. Homeland Security Secretary Markwayne Mullin has pledged to protect American workers from being undercut by foreign companies that rely on forced labor.
Beijing and BGI push back
China rejected the forced labor accusations and denounced the ban as political manipulation and bullying carried out in the name of human rights. In a statement Thursday morning, China's Ministry of Commerce said the listings contradict the consensus reached by the two countries' leaders, threaten the stability of bilateral trade relations, and that China will take necessary measures to protect its interests. Beijing has long dismissed the Xinjiang allegations as false, describing its policies in the region as counterterrorism and stability efforts.
BGI Group also denied the claims, stating Wednesday that it "has not engaged in any form of forced labor" and opposes forced labor in all forms.
Biotech becomes a new front
The move highlights biotechnology as a growing area of economic and technological rivalry between Washington and Beijing. Last week, the Treasury Department proposed new limits on U.S. investment in biotechnology, artificial intelligence and supercomputing in countries such as China.
BGI Group has drawn scrutiny from U.S. lawmakers and officials for years over concerns that its alleged government ties and access to vast amounts of genetic data could threaten U.S. national security and commercial interests. The company has emphasized that it is privately owned, does not serve patients in the United States and has no access to Americans' genetic data. The Pentagon has designated BGI Group, BGI Genomics and MGI Tech as Chinese military companies.
Congress did not pass a bill that would have barred BGI from working with federally funded medical providers, but late last year it approved a similar measure that did not name specific companies and instead called for a list of biotechnology companies of concern.
The latest trade action comes ahead of an expected meeting next month between Chinese leader Xi Jinping and President Donald Trump in Shenzhen, where BGI Group is headquartered. Xi may also travel to Florida in December for the Group of 20 leaders summit, which would mark a fourth meeting between the two leaders this year as they seek to keep relations steady under a trade truce.
Related listings
-
Trump administration asks Supreme Court to lift halt on Big Bend border wall
Supreme Court News 10/27/2026The Trump administration on Wednesday filed an emergency application with the U.S. Supreme Court, asking the justices to set aside a lower court order that has stopped construction of border barriers through the Big Bend region of Texas.The order is ...
-
Supreme Court agrees to review a Reconstruction-era ban on distilling spirits
Supreme Court News 10/21/2026The Supreme Court agreed on Monday to consider whether Congress had the constitutional authority to impose a ban on distilling spirits in private homes more than 150 years ago.Plaintiffs challenging the prohibition on home distilling claim the 1868 l...
-
Bolsonaro and Lula head to a runoff in Brazil's presidential election
Supreme Court News 10/05/2026Sen. Flávio Bolsonaro, an ally of U.S. President Donald Trump, and Brazil's incumbent President Luiz Inácio Lula da Silva will face off in a runoff Oct. 25 for the top job of Latin America's powerhouse economy after neither won a majority in Sunday's...
Our Eugene Oregon Bankruptcy Practice
Since 2005, Erin Uhlemann has helped individuals and families facing financial difficulties file for bankruptcy relief. Erin's compassion and understanding of the law have helped hundreds of Oregonians achieve a financial fresh start. She started Willamette Valley Bankruptcy to focus on helping clients with bankruptcy and debt issues in the Lane County Area. Erin understands that choosing a bankruptcy attorney who makes you feel comfortable and confident can be as difficult as deciding whether to file a bankruptcy case. Because she knows that filing bankruptcy is not something that you planned to do or look forward to doing, Erin strives to make the process as easy as possible.
Because most people facing bankruptcy do not have extra money to pay fees, Willamette Valley Bankruptcy offers low upfront fees and will work with you to set up affordable payment plans to pay attorney fees and court filing fees. Consultations are always free so that you can get the answers you need before making any sort of financial commitment. If you have questions about attorney fees and payment plans, you can call or email today to get these questions answered.
